Development and evaluation of a novel modified release pellet-based system for the delivery of desloratadine and pseudoephedrine hydrochloride
Main Article Content
Abstract
desloratadine and sustained release pellets containing pseudoephedrine hydrochloride.The immediate and sustained release pellets were prepared by solution layering technique. A 32 full-factorial design was employed to optimize the sustained release formulation where in polymer ratio (Ethyl cellulose : hydroxyl propyl methyl cellulose) (X1) and % polymer coating (X2) were taken as independent variables and amount of drug release, in 0.1N HCl (Y1), after 10 haves (Y2) were taken as the dependent variables. Optimization studies were carried out using the Design Expert Software. Formulations were
evaluated for in vitro release studies, the release data were evaluated by the model dependent (curve fitting) method using the PCP Disso software. The in vitro drug release followed Hixson-Crowell model and the drug release mechanism was found to be anomalous or non-fickian type. It was found that proper combination of ethyl cellulose and hydroxy propyl methyl cellulose polymer, % polymer coating and process parameters could provide sustained release of pseudoephedrine hydrochloride for a period of 12 haves.
Downloads
Article Details
This is an Open Access article distributed under the terms of the Attribution-Noncommercial 4.0 International License [CC BY-NC 4.0], which requires that reusers give credit to the creator. It allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, for noncommercial purposes only.
References
Bodmeier R. Tableting of coated pellets. Eur J Pharm Biopharm
;43:1-8.
Bechgaard H, Neilson GH. Controlled release multiple units and single-
unit doses. Drug Dev Ind Pharm 1978;4:53-67.
Bechgaard H. Critical factors influencing gastrointestinal absorption
what is the role of pellets. Acta Pharm Technol 1982;28:149-57.
Wilson CG, Washington C, Washington N. Overview of epithelial barriers
and drug transport. In: Wilson CG, Washington N, editors. Physiological
pharmaceutics: biological barriers to drug absorption. Chichester: Ellis
Horwood Limited; 1989. p. 60-70.
Beckett AH. Proceedings of an International Symposium on Recent
Advances in the Design, Development and Assessment of Sustained
Release Drug Delivery Systems: 1985;Liverpool.
Connell JT. A novel method to assess antihistamine and decongestant
efficacy. Ann Allergy 1979;42:278-85.
Falliers CJ, Redding MA. Controlled comparison of a new antihistamine-
decongestant combination to its individual components. Ann Allergy
;45:75-80.
Connell JT, Williams BO, Allen S, Cato A, Perkins JG. A double blind
controlled evaluation of Actifed and its individual constituents in
allergic rhinitis. J Int Med Res 1982;10:341-7.
Zeeshan F, Bukhari NI. Development and evaluation of a novel modified-
release pellet-based tablet system for the delivery of loratadine and
pseudoephedrine hydrochloride as model drugs. AAPS PharmSciTech
;11:910-6.
Patel HP, Patel JK, Patel RR. Formulation development & optimization
of multiple unit particales system (MUPS) containing ramipril and
hydrochlorothiazide. Int J Pharm Sci 2010;2:448-56.
Rowe RC, Sheskey PJ, Weller PJ, Handbook of Pharmaceutical Exipients.
th ed, London: Pharmaceutical Press; 2003. p. 115-6.
Pandit A, Shinde R. Development and in vitro evaluation of sustained
release multiparticulate tablet of freely water soluble drug. Braz J Pharm
Sci 2010;46:3.
Costa P, Sousa Lobo JM. Modeling and comparison of dissolution
profiles. Eur J Pharm Sci 2001;13:123-33.
Salunke RJ, Shahi SR, Atram SC, Neb GB, Patil S. Formulation and
Evaluation of Hydrodynamically balanced system of Ciprofloxacin HCl.
Int J Pharm Res Dev 2009;(7); article 001.